Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Coronary Artery Disease (CAD): full-pipeline trial registry
2 of 6 indexed Coronary Artery Disease (CAD) trials are currently recruiting.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 2 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Coronary Artery Disease (CAD): 6 US clinical trials tracked, 2 recruiting.
Coronary Artery Disease (CAD) is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is HeartFlow, running 2 of these trials.
Enrollment posture brief
Registry condition coronary-artery-disease-cad
OPEN 2 | RECR 33% | LATE 1 | EARLY 1 | RANK #2866 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Coronary Artery Disease (CAD) lists 2 open slots (33% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Coronary Artery Disease (CAD) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Coronary Artery Disease (CAD) is recruiting below its size-band peers.
2 of 6 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Coronary Artery Disease (CAD) research.
HeartFlow accounts for 2 of 6 trials (33.3%). 5 distinct sponsors appear on at least one study for this condition label.
-
Typical Coronary Artery Disease (CAD) enrolment sits around 277 participants.
Median target enrolment is 277 among the 6 trials that report a genuine target (sentinel values excluded). 3 of those (50%) plan for fewer than 100 participants.
-
Coronary Artery Disease (CAD) research leans observational.
2 interventional and 4 observational studies make up this index (33.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
The NAVIGATE-PCI Registry: A New Approach to VIew CT-derived Guidance Ahead of Stenting To Plan Efficient PCI
HeartFlow
NCT07479433
Using CTA Measures to Define Cardiac Risk In NFL Alumni
HeartFlow
NCT06831409
A Study to Assess the Engagement and Usefulness of Care4Today Digital Platform for Disease Management in Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD) Population
Janssen Scientific Affairs
NCT06052319
Impact of Chronic Kidney Disease on Clopidogrel Effects in Diabetes Mellitus
University of Florida
NCT03774394
Endothelial Progenitor Cells and Nitric Oxide in Cardiac Rehabilitation Program Participants
National Heart, Lung, and Blood Institute (NHLBI)
NCT00308633
Beating the Blues for Your Heart
Indiana University
NCT01605552
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Coronary Artery Disease (CAD) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Coronary Artery Disease (CAD) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Coronary Artery Disease (CAD) page
6 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Coronary Artery Disease (CAD) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- HeartFlow sponsors the most Coronary Artery Disease (CAD) trials on record, review their full trial history before evaluating a specific study. See HeartFlow's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Coronary Artery Disease (CAD) condition card totals 6 registered trials; most-linked intervention Clopidogrel active metabolite; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.